Clinical Trials › NCT07346703
Enrolling by InvitationNA
Effects of DHA in Patients With Multiple Sclerosis
Sponsored by Francisco Javier Martínez Noguera
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 100
Target enrollment
Jan 2026
Start date
Jul 2026
Expected completion
Interventions / Treatments
Docosahexaenoic Acid (DHA) Dietary SupplementSunflower Oil
Conditions studied
Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
